Anavex's European Dream for Blarcamesine Hits a Regulatory Wall A Glimmer of Hope: Blarcamesine's Enduring Promise for Rett Syndrome Taysha Gene Therapies' TSHA-102 Receives FDA Breakthrough Status: A New Hope for Rett Syndrome Anavex Life Sciences Unveils Landmark Publication: Blarcamesine Heralds a New Era in Neurological Treatment